======= DNPH1 ======= == Gene Information == * **Official Symbol**: DNPH1 * **Official Name**: 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10591|10591]] * **UniProt**: [[https://www.uniprot.org/uniprot/O43598|O43598]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DNPH1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DNPH1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/618762|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Catalyzes the cleavage of the N-glycosidic bond of deoxyribonucleoside 5'-monophosphates to yield deoxyribose 5- phosphate and a purine or pyrimidine base. Deoxyribonucleoside 5'- monophosphates containing purine bases are preferred to those containing pyrimidine bases. {ECO:0000255|HAMAP-Rule:MF_03036, ECO:0000269|PubMed:24260472, ECO:0000269|PubMed:25108359}. |Nuc deoxyrib tr| |deoxyribonucleoside 5-monophosphate N-glycosidase activity| |deoxyribonucleoside monophosphate catabolic process| |nucleoside monophosphate catabolic process| |deoxyribonucleoside monophosphate metabolic process| |purine nucleotide catabolic process| |purine-containing compound catabolic process| |nucleotide catabolic process| |nucleoside phosphate catabolic process| |nucleoside monophosphate metabolic process| |nucleobase-containing small molecule biosynthetic process| |nucleoside metabolic process| |organophosphate catabolic process| |glycosyl compound metabolic process| |positive regulation of cell growth| |positive regulation of growth| |purine nucleotide metabolic process| |purine-containing compound metabolic process| |nucleobase-containing compound catabolic process| |regulation of cell growth| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |aromatic compound catabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |organic cyclic compound catabolic process| |nucleobase-containing small molecule metabolic process| |small molecule biosynthetic process| |regulation of growth| |epithelial cell differentiation| |protein homodimerization activity| |organophosphate metabolic process| |carbohydrate derivative metabolic process| |organonitrogen compound catabolic process| |identical protein binding| |nucleobase-containing compound biosynthetic process| |epithelium development| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| |tissue development| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|-4.79| |[[:results:exp512|Olaparib 4μM R08 exp512]]|-3.97| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-2.42| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10967 * **Expression level (log2 read counts)**: 3.78 {{:chemogenomics:nalm6 dist.png?nolink |}}